Antti Viitala

Magnetic resonance guided high intensity focused ultrasound (MR‐HIFU) effectively reduces fibroid‐related symptoms and improves quality of life—A prospective single‐centre 12‐month follow‐up study (2025)

Acta Obstetricia et Gynecologica Scandinavica

Otonkoski, Saara; Viitala, Antti; Komar, Gaber; Sainio, Teija; Yanovskiy, Anna; Blanco Sequieros, Roberto; Perheentupa, Antti; Joronen, Kirsi

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Magnetic resonance imaging-guided transurethral ultrasound ablation for benign prostatic obstruction: 1-year clinical outcomes of a phase II study (2025)

BJU International

Viitala, Antti; Anttinen, Mikael; Mäkelä, Pietari; Pärssinen, Heikki; Nurminen, Pertti; Sainio, Teija; Saunavaara, Jani; Taimen, Pekka; Sequeiros, Roberto Blanco; Boström, Peter J.

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Assessing blood flow in uterine fibroids using intravoxel incoherent motion imaging compared with dynamic contrast-enhanced MRI (2025)

Scientific Reports

Sainio, Teija; Saunavaara, Jani; Komar, Gaber; Viitala, Antti; Otonkoski, Saara; Joronen, Kirsi; Perheentupa, Antti; Sequeiros, Roberto Blanco

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Histological findings in resected leiomyomas following MR-HIFU treatment, single-institution data from seven patients with unfavorable focal therapy (2023)

International Journal of Hyperthermia

Viitala Antti, Gabriel Michael, Joronen Kirsi, Komar Gaber, Perheentupa Antti, Sainio Teija, Huvila Jutta, Pikander Pekka, Taimen Pekka, Blanco Sequeiros Roberto

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Magnetic resonance imaging-guided transurethral ultrasound ablation for benign prostatic hyperplasia: 12-month clinical outcomes of a phase I study (2021)

BJU International

Viitala Antti, Anttinen Mikael, Wright Cameron, Virtanen Ilari, Mäkelä Pietari, Hovinen Topi, Sainio Teija, Saunavaara Jani, Taimen Pekka, Sequeiros Roberto Blanco, Boström Peter J

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Feasibility of T2 relaxation time in predicting the technical outcome of MR-guided high-intensity focused ultrasound treatment of uterine fibroids (2021)

International Journal of Hyperthermia

Sainio Teija, Saunavaara Jani, Komar Gaber, Otonkoski Saara, Joronen Kirsi, Viitala Antti, Perheentupa Antti, Blanco Sequeiros Roberto

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Salvage Magnetic Resonance Imaging–guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer: 12-Month Functional and Oncological Results (2020)

European Urology Open Science

Mikael Anttinen, Pietari Mäkelä, Antti Viitala, Pertti Nurminen, Visa Suomi, Teija Sainio, Jani Saunavaara, Pekka Taimen, Roberto Blanco Sequeiros, Peter J. Boström

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Antti

Viitala

Contact

Publications

Sort by:

Magnetic resonance guided high intensity focused ultrasound (MR‐HIFU) effectively reduces fibroid‐related symptoms and improves quality of life—A prospective single‐centre 12‐month follow‐up study (2025)

Magnetic resonance imaging-guided transurethral ultrasound ablation for benign prostatic obstruction: 1-year clinical outcomes of a phase II study (2025)

Assessing blood flow in uterine fibroids using intravoxel incoherent motion imaging compared with dynamic contrast-enhanced MRI (2025)

Histological findings in resected leiomyomas following MR-HIFU treatment, single-institution data from seven patients with unfavorable focal therapy (2023)

Magnetic resonance imaging-guided transurethral ultrasound ablation for benign prostatic hyperplasia: 12-month clinical outcomes of a phase I study (2021)

Feasibility of T2 relaxation time in predicting the technical outcome of MR-guided high-intensity focused ultrasound treatment of uterine fibroids (2021)

Salvage Magnetic Resonance Imaging–guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer: 12-Month Functional and Oncological Results (2020)